TARO-TESTOSTERONE GEL
TARO PHARMACEUTICALS INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TARO-TESTOSTERONE GEL in Canada?
Yes. TARO-TESTOSTERONE GEL 1% has an active shortage reported to Health Canada (last updated October 29, 2026).
Why is TARO-TESTOSTERONE GEL not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TARO-TESTOSTERONE GEL be available again?
The manufacturer's estimated resolution date is November 20, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TESTIM 1%
KNIGHT THERAPEUTICS INC.
TARO-TESTOSTERONE GEL
TARO PHARMACEUTICALS INC
Other Products
NATESTO
ACERUS BIOPHARMA INC
TARO-TESTOSTERONE
TARO PHARMACEUTICALS INC
TESTOSTERONE ENANTHATE INJECTION, USP
HIKMA CANADA LIMITED
KYZATREX
HIKMA CANADA LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02463792
Strength
1%
Dosage Form
GEL
Route
TRANSDERMAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366